US FDA grants approval for BMS’ Sotyktu to treat plaque psoriasis
The approval is based on data from the Phase III POETYK PSO-1 and POETYK PSO-2 trials.
Autoimmune Disorders
Latest in
Autoimmune Disorders
Sonoma signs deal to set up manufacturing centre for cell therapies
A cGMP-compliant production facility will be housed at the centre for manufacturing cell products at scale.
Q32 Bio and Horizon partner to develop autoimmune disease treatment
Q32 is entitled to get $55m as initial consideration and staged development funding during the option period.
Amgen to acquire biopharma firm ChemoCentryx for $3.7bn
The board of directors of Amgen and ChemoCentryx has granted unanimous approval for the acquisition.
Gilead Sciences signs agreement to acquire MiroBio for $405m
Gilead will gain access to the discovery platform and complete line of the immune inhibitory receptor agonists of MiroBio.
US FDA grants approval for Janssen’s Stelara to treat psoriatic arthritis
A completely human monoclonal antibody, Stelara hinders cytokines IL-12 and IL-23.
US FDA grants approval to Incyte’s Opzelura cream for vitiligo treatment
The approval was based on findings from Phase III TRuE-V clinical trial programme of Opzelura in nonsegmental vitiligo patients.
Pierre Fabre and Lonza sign antibody manufacturing agreement
W0180 is presently being analysed in a Phase I clinical trial for various solid tumours.